Markus Flepp - Concepedia

Author

Markus Flepp

Also Known As

A Telenti, Amalio Telenti, Eric Sandstrom, J Fellay, M Fischer, M Flepp, M. Fischer, M. Flepp, Markus Flepp, Markus J. Flepp

125

Publications

8.4K

Citations

H-Index

102

Concepts

All Affiliations

University Hospital of Zurich University of Zurich University Hospital of Bern University Hospital of Geneva University of Lausanne

About

Markus Flepp is an author at University Hospital of Zurich specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	25	3.6K
2	Public Health	8	8	1.7K
3	Social Sciences	3	3	120
4	Health Sciences	1	1	135
5	Allergy	1	1	25

Markus Flepp

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study Bruno Ledergerber, Matthias Egger, Milos Opravil, The Lancet Treatment And PreventionNeurovirologyHuman RetrovirusActive Antiretroviral TherapyHiv-1 Patients	1999	933
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Gilbert Greub, B Ledergerber, Manuel Battegay, The Lancet Antiretroviral TherapyHepatitis CTreatment And PreventionViral HepatitisHuman Retrovirus	2000	901
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study Matthias Egger, Bernard Hirschel, P Francioli, BMJ	1997	623
Decreasing mortality and changing patterns of causes of death in the <scp>S</scp>wiss <scp>HIV C</scp>ohort <scp>S</scp>tudy Rainer Weber, M Ruppik, Martin Rickenbach, HIV Medicine	2012	358
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Jacques Fellay, Bruno Ledergerber, Enos Bernasconi, The Lancet Sexual HealthAdverse EventsEpidemiological OutcomeTreatment And PreventionAdverse Event	2001	329
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV Pietro Vernazza, Luigi Troiani, Markus Flepp, AIDS	2000	273
Discontinuation of Primary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy Hansjakob Furrer, Matthias Egger, Milos Opravil, New England Journal of Medicine	1999	254
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance Sabine Yerly, Samir Vora, P. Rizzardi, AIDS	2001	238
Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study Karim Boubaker, Markus Flepp, Philippe Sudre, Clinical Infectious Diseases	2001	215
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Stefano Bassetti, M Battegay, H Furrer, PubMed PharmacotherapyAntiviral DrugAdverse Drug ReactionPreventive MedicineHiv/aids Counselling	1999	160

Page 1